Kitakatsuragi-gun, Japan

Tetsuji Imamoto


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 57(Granted Patents)


Location History:

  • Katsuragi, JP (1993 - 1995)
  • Kitakatsuragi-gun, JP (1996 - 2001)

Company Filing History:


Years Active: 1993-2001

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Tetsuji Imamoto: Innovator in Pharmaceutical Science

Introduction

Tetsuji Imamoto is a notable inventor based in Kitakatsuragi-gun, Japan. He has made significant contributions to the field of pharmaceutical science, particularly in the treatment of cerebral conditions. With a total of 6 patents to his name, Imamoto's work has the potential to impact many lives.

Latest Patents

Among his latest patents, one focuses on the treatment of cerebral infarction using cyclic hexapeptides. This pharmaceutical composition comprises a compound that exhibits anti-endothelin activity, which is useful for the prophylaxis or treatment of cerebral infarction. Another significant invention is an inhibitor of vascular permeability enhancer. This invention relates to the prevention or treatment of brain edema, intracranial hemorrhage, and cerebral infarction by administering a pharmaceutically effective amount of a compound or a pharmaceutically acceptable salt thereof.

Career Highlights

Tetsuji Imamoto is currently associated with Takeda Chemical Industries, Inc., a leading company in the pharmaceutical sector. His work at Takeda has allowed him to focus on innovative solutions for complex medical issues.

Collaborations

Imamoto has collaborated with notable coworkers such as Giichi Goto and Hidefumi Yukimasa. These collaborations have likely contributed to the advancement of his research and inventions.

Conclusion

Tetsuji Imamoto's contributions to pharmaceutical science through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in the treatment of cerebral conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…